Takara Bio USA, Inc. specializes in advanced biotechnological solutions aimed at enhancing clinical and molecular research. One of their notable innovations is the SmartChip ND Real-Time PCR System, which offers a high-throughput, cost-effective approach to quantitative PCR (qPCR) specifically designed for infectious disease research. This automated system streamlines laboratory workflows, enabling faster and more efficient data collection. Additionally, Takara Bio's PicoPLEX technology is pivotal in preimplantation genetic testing (PGT), allowing for unbiased amplification of genomic DNA from minimal input samples, such as single cells. This technology significantly improves the accuracy and reliability of genetic screenings, thereby enhancing the chances of successful pregnancies through in vitro fertilization (IVF).

In the realm of next-generation sequencing (NGS), Takara Bio provides a comprehensive suite of products that facilitate various applications, including RNA-seq and DNA-seq. Their SMART-Seq technology is particularly noteworthy for its ability to generate high-quality cDNA libraries from single cells, which is crucial for understanding gene expression and function at a granular level. Furthermore, the company offers custom enzyme services and a range of reagents and kits that support diverse research needs, from gene editing to protein purification. By integrating these advanced technologies, Takara Bio USA aims to accelerate scientific discovery and improve outcomes in clinical research and diagnostics.

United States

Takara Bio USA, Inc. (formerly Clontech Laboratories, Inc.), a Takara Bio company, develops, manufactures, and distributes a wide range of life science reagents under the Takara®, Cellartis®, and Clontech® brands. Our products support applications including stem cell research; NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi and gene editing; and plant and food research.

Takara Bio USA, Inc.

Company Details